These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 21178684)

  • 1. Why no casopitant-only arm?
    Anixter MB
    Anesthesiology; 2011 Jan; 114(1):224-5; author reply 225. PubMed ID: 21178684
    [No Abstract]   [Full Text] [Related]  

  • 2. Casopitant and ondansetron for postoperative nausea and vomiting prevention in women at high risk for emesis: a phase 3 study.
    Altorjay A; Melson T; Chinachoit T; Kett A; Aqua K; Levin J; Blackburn LM; Lane S; Pergolizzi JV
    Arch Surg; 2011 Feb; 146(2):201-6. PubMed ID: 21339433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study to evaluate the safety and efficacy of the oral neurokinin-1 receptor antagonist casopitant (GW679769) administered with ondansetron for the prevention of postoperative and postdischarge nausea and vomiting in high-risk patients.
    Singla NK; Singla SK; Chung F; Kutsogiannis DJ; Blackburn L; Lane SR; Levin J; Johnson B; Pergolizzi JV
    Anesthesiology; 2010 Jul; 113(1):74-82. PubMed ID: 20526194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase III trial of casopitant, a novel neurokinin-1 receptor antagonist, for the prevention of nausea and vomiting in patients receiving moderately emetogenic chemotherapy.
    Herrstedt J; Apornwirat W; Shaharyar A; Aziz Z; Roila F; Van Belle S; Russo MW; Levin J; Ranganathan S; Guckert M; Grunberg SM
    J Clin Oncol; 2009 Nov; 27(32):5363-9. PubMed ID: 19805683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-operative nausea and vomiting prevention with perphenazine: long overdue.
    Williams BA; Orebaugh SL; Kentor ML
    Eur J Anaesthesiol; 2011 Feb; 28(2):141-2. PubMed ID: 20962658
    [No Abstract]   [Full Text] [Related]  

  • 6. Haloperidol plus ondansetron versus ondansetron alone for prophylaxis of postoperative nausea and vomiting.
    Grecu L; Bittner EA; Kher J; Smith SE; Rosow CE
    Anesth Analg; 2008 May; 106(5):1410-3, table of contents. PubMed ID: 18420853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haloperidol for postoperative nausea and vomiting: are we reinventing the wheel?
    Habib AS; Gan TJ
    Anesth Analg; 2008 May; 106(5):1343-5. PubMed ID: 18420842
    [No Abstract]   [Full Text] [Related]  

  • 8. Casopitant, a neurokinin-1 receptor antagonist with anti-emetic and anti-nausea activities.
    Navari RM
    Curr Opin Investig Drugs; 2008 Jul; 9(7):774-85. PubMed ID: 18600583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase 2 trial results with the novel neurokinin-1 receptor antagonist casopitant in combination with ondansetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in cancer patients receiving moderately emetogenic chemotherapy.
    Arpornwirat W; Albert I; Hansen VL; Levin J; Bandekar RR; Grunberg SM
    Cancer; 2009 Dec; 115(24):5807-16. PubMed ID: 19834961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haloperidol versus ondansetron for prophylaxis of postoperative nausea and vomiting.
    Rosow CE; Haspel KL; Smith SE; Grecu L; Bittner EA
    Anesth Analg; 2008 May; 106(5):1407-9, table of contents. PubMed ID: 18420852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol vs. ondansetron for the prevention of postoperative nausea and vomiting following gynaecological surgery.
    Aouad MT; Siddik-Sayyid SM; Taha SK; Azar MS; Nasr VG; Hakki MA; Zoorob DG; Baraka AS
    Eur J Anaesthesiol; 2007 Feb; 24(2):171-8. PubMed ID: 16938159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of postoperative nausea and vomiting.
    Yalçýn S; Yalçýn B; Büyükçelik A
    N Engl J Med; 2004 Sep; 351(14):1458-9; author reply 1458-9. PubMed ID: 15459310
    [No Abstract]   [Full Text] [Related]  

  • 13. [Ondansetron usage in prophylaxis of postoperative nausea and vomiting in children operated for posterior cranial fossa tumors].
    Tseĭtlin AM; Sorokin VS; Lemeneva NV; Lubnin AIu; Savin IA
    Anesteziol Reanimatol; 2003; (3):63-4. PubMed ID: 12918207
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of ondansetron, dexamethasone, ondansetron plus dexamethasone and placebo in the prevention of nausea and vomiting after laparoscopic tubal ligation.
    Biswas BN; Rudra A; Mandal SK
    J Indian Med Assoc; 2003 Nov; 101(11):638, 640, 642. PubMed ID: 15198411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy.
    Elhakim M; Nafie M; Mahmoud K; Atef A
    Can J Anaesth; 2002 Nov; 49(9):922-6. PubMed ID: 12419717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midazolam vs ondansetron for preventing postoperative nausea and vomiting.
    Timms G
    Anaesthesia; 2007 Jun; 62(6):636-7; author reply 637. PubMed ID: 17506756
    [No Abstract]   [Full Text] [Related]  

  • 17. Casopitant: a new warrior in the antiemetic crusade.
    Khojasteh A; Khojasteh A; Thornburg BG; Maher KR
    Expert Opin Pharmacother; 2009 Jun; 10(8):1367-76. PubMed ID: 19445564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prophylactic anti-emetic efficacy of ramosetron and ondansetron in patients at high-risk for postoperative nausea and vomiting after total knee replacement.
    Hahm TS; Ko JS; Choi SJ; Gwak MS
    Anaesthesia; 2010 May; 65(5):500-4. PubMed ID: 20337618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron has similar clinical efficacy against both nausea and vomiting.
    Jokela RM; Cakmakkaya OS; Danzeisen O; Korttila KT; Kranke P; Malhotra A; Paura A; Radke OC; Sessler DI; Soikkeli A; Roewer N; Apfel CC
    Anaesthesia; 2009 Feb; 64(2):147-51. PubMed ID: 19143691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropisetron vs ondansetron for prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy: a randomized double-blind, placebo-controlled study.
    Argiriadou H; Papaziogas B; Pavlidis T; Parlapani A; Georgiou M; Papagiannopoulou P; Papaziogas T
    Surg Endosc; 2002 Jul; 16(7):1087-90. PubMed ID: 12165828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.